Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials; Public Meeting - 02/02/2021 - 02/03/2021

The meeting is intended to gather industry, patient, clinician, researcher, institutional review board, ethicist, professional society and other stakeholder input on the scientific and ethical issues that surround the inclusion of pregnant women in clinical trials for drug development.

Source: FDA Center for Drug Evaluation and Research - What's New - January 5, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news